Metabolism and Disposition of [14C]BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor, after Oral Administration to Humans-Reference-Cited by-同舟云学术

Metabolism and Disposition of [14C]BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor, after Oral Administration to Humans

Published:2010-07-28 Issue:11 Volume:38 Page:2049-2059
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Christopher Lisa J.,Hong Haizheng,Vakkalagadda Blisse J.,Clemens Pamela L.,Su Hong,Roongta Vikram,Allentoff Alban,Sun Haojun,Heller Kevin,Harbison Christopher T.,Iyer Ramaswamy A.,Humphreys William G.,Wong Tai,Zhang Steven

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference28 articles.

1. Phase I multicenter trial of BMS-690514: safety, pharmacokinetic profile, biological effects, and early clinical evaluation in patients with advanced solid tumors and non-small cell lung cancer;Bahleda;J Clin Oncol,2008

2. Bahleda R Soria J Harbison C Park J Felip E. Hanna N Laurie SA Armand J Shepherd FA Herbst R (2009) Tumor regression and pharmacodynamic (PD) biomarker validation in non-small cell lung cancer (NSCLC) patients treated with the ErbB/VEGFR inhibitor BMS-690514. J Clin Oncol 27 (15s):abstr 8098.

3. Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry

4. Pharmacokinetic Investigation of Imatinib Using Accelerator Mass Spectrometry in Patients with Chronic Myeloid Leukemia

5. Bracco Diagnostics (2004) Kinevac® (sincalide for injection) prescribing information. Bracco Diagnostics, Princeton, NJ.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co‐consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants;Clinical and Translational Science;2023-08-28

2. Design, conduct, and interpretation of human mass balance studies and strategies for assessing metabolites-in-safety testing (MIST) in drug development;Overcoming Obstacles in Drug Discovery and Development;2023

3. Enterohepatic circulation of glucuronide metabolites of drugs in dog;Pharmacology Research & Perspectives;2019-07-04

4. Regulatory aspects of human radiolabeled mass balance studies in oncology: concise review;Drug Metabolism Reviews;2016-04-02

5. Identification of drug metabolites in human plasma or serum integrating metabolite prediction, LC–HRMS and untargeted data processing;Bioanalysis;2013-09